by Dr. Felix Gremse, RWTH Aachen University and Gremse IT
Hybrid fluorescence tomography and x-ray computed tomography (FLT-CT) provided by the MILabs OI-CT system allows non-invasive longitudinal volumetric assessment of fluorescent probes in mice in vivo. This talk demonstrates that FLT-CT can be used to quantitatively determine the biodistribution NIRF-labeled probes. It also demonstrates the functionality for multimodal bioluminescence tomography (BLT-CT) which uses multispectral images to identify deep luminescent sources such as luciferase-expressing tumors and metastases.
Took place: August, 2020 (at vEMIM)
Duwboot 7a
3991 CD Houten
The Netherlands
Phone: +31 85 088 5753
Fax: +31 88 756 0094
E-mail: [email protected]
REQUEST MORE INFORMATION
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.